ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $560,745 | -31.0% | 102,889 | -15.1% | 0.39% | -53.4% |
| Q2 2023 | $813,024 | -21.0% | 121,166 | +4.0% | 0.83% | +20.2% |
| Q1 2023 | $1,029,225 | -36.1% | 116,560 | -44.7% | 0.69% | -48.9% |
| Q4 2022 | $1,610,550 | -26.0% | 210,805 | -31.1% | 1.36% | +8.2% |
| Q3 2022 | $2,177,000 | -18.5% | 305,805 | -7.3% | 1.25% | -49.0% |
| Q2 2022 | $2,670,000 | -35.2% | 329,981 | +11.1% | 2.45% | -26.8% |
| Q1 2022 | $4,123,000 | +113.2% | 297,048 | +330.9% | 3.35% | +182.6% |
| Q4 2021 | $1,934,000 | – | 68,940 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |